Search results for "kings college london"

SARS-CoV-2 Spike-E-M Mosaic protein is a recombinant antigen manufactured in E. coli with greater than 95% purity, and containing the Spike (S), Envelope (E) and Membrane (M) immunodominant regions. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.

New blood test provides a unique new framework for early detection of the most common cancers

Session Overview from the 7th International Symposium: Clinical Applications of Free Light Chain and Heavy/Light Chain Analysis

There are several promising areas of research that could enable earlier diagnosis of Alzheimer’s disease

Have you considered all the factors affecting the accuracy and reliability of your weighing processes using a semi-micro balance?

Machine-learning system determines the fewest, smallest doses that could still shrink brain tumors

Dr. Andy Golden, senior investigator at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), explores the value of C. elegans as an animal model for research

How Molecular Diagnostics is revolutionizing the way infectious diseases are diagnosed

Guest Editor, Randall Evans, Ph.D of Biodesix, discusses the recent success of a clinical trial of a diagnostic blood test

PCR oligonucleotide primer sets consisting of 16  primers  for amplification and 16 primers  for cloning of human IgG and IgM heavy and light chain variable domain coding regions for generating universal, patient or antibody-specific scFv phage-display libraries. 

Novel Coronavirus 2019-nCoV (SARS-CoV-2) Spike Glycoprotein (S1) is a recombinant antigen which contains the Spike protein amino acids 1-674. Spike S1 protein is manufactured in HEK293 mammalian cells, ensuring the most authentic post-translational modifications.

Novel Coronavirus 2019-nCoV (SARS-CoV-2) Spike Glycoprotein (S2) is a recombinant antigen which contains the Spike S2 protein, amino acids 685-1211. Spike S2 is manufactured in mammalian HEK293 cells to ensure the most authentic post-translational modifications.

Watch this on-demand webinar to learn how risk-based approaches can be implemented to improve the control of impurities

Join a panel of scientific experts as they reveal groundbreaking COVID-19 and cancer research projects, share insights into cryogenics, and explore why we no longer need to rely on liquid nitrogen based cryogenic freezers for sample storage

Dr. Joseph Hughes describes how WuXi Advanced Therapies scales up viral vectors to help customers expedite entry of gene and cell therapies into clinical trials

Read how Dr Jason Sylvan samples microbes from the depths of the ocean and performs experiments on a ship

Discover how Dr. Nicholas Zachos, Johns Hopkins Medicine, uses patient-derived stem cells to create complex co-cultures with the aim of developing new therapeutics to prevent diarrheal disease